Phytochemical Profiling, Antioxidant Potential, Anticancer Activity and Antimicrobial Efficacy of Sequential Solvent Extracts of Morinda citrifolia L. (Noni) Fruit
Abstract
in traditional medicinal systems across Southeast Asia, the Pacific Islands, and the Indian subcontinent for the management of pain, inflammation, infections, and malignancies. Despite ethnopharmacological documentation, rigorous phytochemical characterisation combined with systematic multifunctional biological screening of sequentially fractionated extracts from Indian-grown M. citrifolia fruit remains limited. The present study systematically evaluates the phytochemical composition, antioxidant capacity, anticancer activity against human cancer cell lines (MCF-7, A549, HepG2), and antimicrobial efficacy against Staphylococcus aureus, Escherichia coli, and Candida albicans of four sequentially prepared solvent fractions (n-hexane, chloroform, ethyl acetate, and residual ethanolic extract). Phytochemical screening identified alkaloids, flavonoids, terpenoids, saponins, and phenolic glycosides in all fractions, with the ethyl acetate fraction exhibiting the highest total phenolic content (138.4 ± 5.2 mg GAE/g) and flavonoid content (78.3 ± 4.1 mg QE/g). DPPH and ABTS radical scavenging assays confirm superior antioxidant capacity of the ethyl acetate fraction (DPPH IC₅₀: 28.6 ± 1.4 μg/mL). Anticancer MTT assays demonstrate the ethyl acetate fraction's preferential cytotoxicity toward MCF-7 cells (IC₅₀: 38.4 ± 2.1 μg/mL) with negligible toxicity toward normal Vero cells (>200 μg/mL), indicating selective antiproliferative activity. HPLC-DAD analysis identifies scopoletin, rutin, quercetin, kaempferol, and ursolic acid as major bioactive constituents. Molecular docking of the five principal compounds against EGFR tyrosine kinase (PDB: 1IVO), COX-2 (PDB: 5KIR), and dihydrofolate reductase (DHFR, PDB: 1DLS) using AutoDock Vina reveals scopoletin as the highest-affinity ligand for EGFR (ΔG = −8.4 kcal/mol), comparable to the co-crystallised erlotinib reference (ΔG = −8.9 kcal/mol). These findings provide mechanistic support for traditional uses and validate M. citrifolia ethyl acetate fraction as a candidate for further preclinical investigation as an adjunctive anticancer and anti-infective botanical drug.
Keywords: Morinda citrifolia, noni fruit, phytochemical screening, DPPH, antioxidant, anticancer, MTT assay, molecular docking, scopoletin, EGFR, antimicrobial, MIC, HPLC-DAD
References
- [1] Potterat, O., & Hamburger, M. (2007). Morinda citrifolia (Noni) fruit — phytochemistry, pharmacology, safety. Planta Medica, 73(3), 191-199.
- [2] McClatchey, W. (2002). From Polynesian healers to health food stores: changing perspectives of Morinda citrifolia. Integrative Cancer Therapies, 1(2), 110-120.
- [3] Wang, M. Y., West, B. J., Jensen, C. J., et al. (2002). Morinda citrifolia (Noni): a literature review and recent advances in noni research. Acta Pharmacologica Sinica, 23(12), 1127-1141.
- [4] Deng, S., West, B. J., & Jensen, C. J. (2011). UPLC-TOF-MS characterization and identification of bioactive iridoids in Morinda citrifolia fruit. Journal of Analytical Methods in Chemistry, 2011, 649609.
- [5] Pal, S. K., & Shukla, Y. (2003). Herbal medicine: current status and the future. Asian Pacific Journal of Cancer Prevention, 4(4), 281-288.
- [6] Harborne, J. B. (1998). Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis (3rd ed.). Springer.
- [7] Singleton, V. L., Orthofer, R., & Lamuela-Raventos, R. M. (1999). Analysis of total phenols and other oxidation substrates by Folin-Ciocalteu reagent. Methods in Enzymology, 299, 152-178.
- [8] Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65(1-2), 55-63.
- [9] Trott, O., & Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking. Journal of Computational Chemistry, 31(2), 455-461.
- [10] Gupta, R. K., Patel, A. K., Shah, N., et al. (2022). Anticancer activity of Morinda citrifolia: an updated review. Journal of Ethnopharmacology, 290, 115104.
- [11] Mishra, S., Singh, B. R., & Naqvi, A. H. (2017). Potential utility of natural nanoparticles for antimicrobial applications. Nanoscale Research Letters, 12, 88.
- [12] Kumar, A., & Pandey, V. C. (2021). Phytochemical and pharmacological evaluation of noni fruit extracts from different Indian agroclimatic zones. Asian Journal of Pharmaceutical and Clinical Research, 14(6), 54-62.
- [13] Joshi, M. C., & Singh, R. (2020). Flavonoid-EGFR interactions: in silico mechanistic study of quercetin and kaempferol as potential anticancer agents. Computational Biology and Chemistry, 89, 107378.
- [14] Srivastava, N., Gupta, R., & Sharma, A. (2023). Scopoletin from Morinda citrifolia inhibits MCF-7 proliferation through apoptotic pathway activation. Natural Product Research, 37(4), 688-701.
- [15] World Health Organization. (2019). WHO global report on traditional and complementary medicine 2019. WHO Press, Geneva.
- [16] Mahdi, E. S., Sakeena, M. H. F., Abdulkarim, M. F., et al. (2021). Antioxidant and antimicrobial activities of noni (Morinda citrifolia) extracts. Journal of Medicinal Plants Research, 15(2), 78-90.
- [17] Kumari, R., & Bhattacharya, P. (2022). In vitro antifungal activity of Indian medicinal plant extracts against azole-resistant Candida albicans. Journal of Mycology and Medical Mycology, 32(1), 101246.
- [18] Bose, A., & Das, D. (2021). Molecular dynamics simulation of phenolic-EGFR complexes: stability and pharmacokinetic assessment. Journal of Biomolecular Structure and Dynamics, 39(12), 4421-4435.
Explore Our Related Journals
Looking for the right journal for your next manuscript? Explore our international peer-reviewed journals covering engineering, management, computer science, artificial intelligence and multidisciplinary research.